nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—SST—autonomic nervous system—attention deficit hyperactivity disorder	0.106	0.236	CbGeAlD
Cysteamine—NPY2R—forebrain—attention deficit hyperactivity disorder	0.0633	0.141	CbGeAlD
Cysteamine—MPO—saliva—attention deficit hyperactivity disorder	0.0418	0.093	CbGeAlD
Cysteamine—NPY2R—nervous system—attention deficit hyperactivity disorder	0.0344	0.0765	CbGeAlD
Cysteamine—NPY2R—central nervous system—attention deficit hyperactivity disorder	0.0331	0.0737	CbGeAlD
Cysteamine—NPY2R—brain—attention deficit hyperactivity disorder	0.0263	0.0585	CbGeAlD
Cysteamine—SST—forebrain—attention deficit hyperactivity disorder	0.0247	0.055	CbGeAlD
Cysteamine—SST—cardiovascular system—attention deficit hyperactivity disorder	0.0209	0.0465	CbGeAlD
Cysteamine—SST—midbrain—attention deficit hyperactivity disorder	0.0163	0.0363	CbGeAlD
Cysteamine—SST—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.0137	0.025	CbGpPWpGaD
Cysteamine—SST—nervous system—attention deficit hyperactivity disorder	0.0134	0.0299	CbGeAlD
Cysteamine—NPY2R—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.0132	0.0239	CbGpPWpGaD
Cysteamine—SST—Mecp2 and Associated Rett Syndrome—BDNF—attention deficit hyperactivity disorder	0.0132	0.0239	CbGpPWpGaD
Cysteamine—SST—central nervous system—attention deficit hyperactivity disorder	0.0129	0.0288	CbGeAlD
Cysteamine—SST—cerebellum—attention deficit hyperactivity disorder	0.0126	0.0281	CbGeAlD
Cysteamine—SST—brain—attention deficit hyperactivity disorder	0.0103	0.0228	CbGeAlD
Cysteamine—MPO—forebrain—attention deficit hyperactivity disorder	0.00996	0.0222	CbGeAlD
Cysteamine—SST—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00922	0.0167	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00884	0.0161	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00883	0.016	CbGpPWpGaD
Cysteamine—MPO—cardiovascular system—attention deficit hyperactivity disorder	0.00842	0.0187	CbGeAlD
Cysteamine—SST—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00833	0.0151	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00821	0.0149	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00804	0.0146	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00798	0.0145	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.0076	0.0138	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00733	0.0133	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00718	0.013	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00706	0.0128	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00706	0.0128	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00703	0.0128	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.00692	0.0126	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00689	0.0125	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00626	0.0114	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.006	0.0109	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00558	0.0101	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00557	0.0101	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.00553	0.01	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00553	0.01	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00547	0.00994	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00547	0.00993	CbGpPWpGaD
Cysteamine—MPO—nervous system—attention deficit hyperactivity disorder	0.00541	0.012	CbGeAlD
Cysteamine—NPY2R—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00535	0.00972	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00535	0.00972	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00531	0.00965	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00525	0.00953	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00524	0.00952	CbGpPWpGaD
Cysteamine—MPO—central nervous system—attention deficit hyperactivity disorder	0.0052	0.0116	CbGeAlD
Cysteamine—NPY2R—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.0052	0.00944	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00513	0.00931	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00498	0.00904	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00493	0.00895	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00487	0.00884	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00484	0.0088	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00484	0.00879	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00478	0.00869	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00477	0.00867	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00473	0.00858	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.0047	0.00854	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00464	0.00843	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00459	0.00833	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00453	0.00822	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00451	0.00819	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00446	0.00809	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00439	0.00796	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00435	0.0079	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00433	0.00787	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00431	0.00783	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00427	0.00776	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00427	0.00776	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00426	0.00773	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00417	0.00758	CbGpPWpGaD
Cysteamine—MPO—brain—attention deficit hyperactivity disorder	0.00413	0.0092	CbGeAlD
Cysteamine—NPY2R—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.0041	0.00744	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00405	0.00735	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00397	0.0072	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00392	0.00711	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00388	0.00704	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00385	0.00699	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.0038	0.00691	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00379	0.00688	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00376	0.00682	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00369	0.0067	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00365	0.00662	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00364	0.0066	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00354	0.00643	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.0034	0.00617	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00331	0.00602	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00318	0.00577	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00316	0.00573	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00309	0.00561	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00308	0.00559	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00303	0.00549	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00298	0.00542	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00296	0.00538	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00295	0.00536	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00293	0.00533	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0029	0.00526	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00287	0.0052	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00286	0.00519	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00281	0.00511	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00281	0.0051	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00278	0.00504	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00278	0.00504	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00275	0.00499	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.0027	0.0049	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00269	0.00489	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00259	0.0047	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00252	0.00458	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00248	0.00451	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00242	0.00439	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00238	0.00432	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.0023	0.00417	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00214	0.00389	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00205	0.00373	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00197	0.00358	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00195	0.00353	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00189	0.00343	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00189	0.00343	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00187	0.0034	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00187	0.00339	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00181	0.00329	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.0018	0.00326	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.0018	0.00326	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00174	0.00316	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.0017	0.00309	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00169	0.00307	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00169	0.00306	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00167	0.00303	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00166	0.00301	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00166	0.00301	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00164	0.00297	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00163	0.00296	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00163	0.00295	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00162	0.00295	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00162	0.00294	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00159	0.00289	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00159	0.00289	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00158	0.00287	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00157	0.00285	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00156	0.00283	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00153	0.00278	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00153	0.00277	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00152	0.00275	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00151	0.00273	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—EP300—attention deficit hyperactivity disorder	0.0015	0.00272	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00149	0.0027	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00147	0.00267	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00146	0.00265	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00144	0.00262	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00143	0.00259	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00138	0.00251	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00133	0.00241	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00115	0.00209	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.0011	0.002	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00107	0.00194	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00102	0.00186	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.001	0.00182	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00097	0.00176	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000963	0.00175	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000934	0.0017	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00093	0.00169	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000905	0.00164	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000896	0.00163	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000889	0.00161	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000878	0.00159	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000867	0.00157	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000853	0.00155	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000842	0.00153	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000818	0.00149	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000784	0.00142	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000573	0.00104	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000549	0.000997	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000304	0.000551	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000291	0.000528	CbGpPWpGaD
